a biosimilar version of the insulin blockbuster Lantus launched today in the US. Basaglar will also undercut Sanofi’s longer lasting version, Toujeo, and is likely to win a large share of the ...

Sanofi's rivals in the insulin field are nipping at its heels – Lantus sales dipped 5 per cent in the first half of 2015, and analysts don't expect Toujeo to make up for its decline.

but it doesn’t cover insulin pens or supplies related to insulin, such as syringes, needles, alcohol swabs, or gauze. Some people opt for a tubeless insulin pump instead. These are newer devices ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

If you use insulin to manage diabetes, you may want to take your protein consumption into consideration when determining your mealtime doses. Protein is made up of molecules called amino acids ...

Home glucose meters can help lower your risk of complications from diabetes. Along with treatment, using a home monitor can help you identify the things that make your blood sugar increase or ...

Managing type 2 diabetes goes beyond diet and exercise—it often involves choosing the right medication. One of the most ...